TY - JOUR
T1 - Metastases from transitional cell carcinoma of urinary bladder
AU - Babaian, Richard J.
AU - Johnson, Douglas E.
AU - Llamas, Luis
AU - Ayala, Alberto G.
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 1980
Y1 - 1980
N2 - In 107 patients who died of metastatic transitional cell carcinoma, the most common sites for metastases at necropsy were the lymph nodes, liver, lung, bone, and adrenal gland. Metastases first were documented clinically in multiple-organ sites in one third of the patients; solitary metastases were present in only 9 patients at necropsy. The mean duration of survival for patients was thirteen months from the diagnosis of the primary tumor. The metastatic lesion(s) generally were evident clinically within eleven months of the primary diagnosis; death ensued usually within three months. Our finding that the majority of patients presented initially with high-grade tumors suggests that a high-grade lesion, regardless of its clinical stage, warrants early aggresive therapy.
AB - In 107 patients who died of metastatic transitional cell carcinoma, the most common sites for metastases at necropsy were the lymph nodes, liver, lung, bone, and adrenal gland. Metastases first were documented clinically in multiple-organ sites in one third of the patients; solitary metastases were present in only 9 patients at necropsy. The mean duration of survival for patients was thirteen months from the diagnosis of the primary tumor. The metastatic lesion(s) generally were evident clinically within eleven months of the primary diagnosis; death ensued usually within three months. Our finding that the majority of patients presented initially with high-grade tumors suggests that a high-grade lesion, regardless of its clinical stage, warrants early aggresive therapy.
UR - http://www.scopus.com/inward/record.url?scp=0018956045&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018956045&partnerID=8YFLogxK
U2 - 10.1016/0090-4295(80)90067-9
DO - 10.1016/0090-4295(80)90067-9
M3 - Article
C2 - 7404907
AN - SCOPUS:0018956045
VL - 16
SP - 142
EP - 144
JO - Urology
JF - Urology
SN - 0090-4295
IS - 2
ER -